发布求助
文献互助 智能选刊 最新文献

Global Journal of Transfusion Medicine最新文献

筛选
英文 中文
Issues related to artificial tears were discussed at the 33rd Regional Congress of the International Society of Blood Transfusion (ISBT) in Gothenburg, June 17–21, 2023 2023年6月17日至21日在哥德堡举行的第33届国际输血学会(ISBT)地区大会上讨论了与人工泪液相关的问题
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.97618
Katarzyna Chmielewska, Joanna Janus, Jolanta Antoniewicz-Papis
{"title":"Issues related to artificial tears were discussed at the 33rd Regional Congress of the International Society of Blood Transfusion (ISBT) in Gothenburg, June 17–21, 2023","authors":"Katarzyna Chmielewska, Joanna Janus, Jolanta Antoniewicz-Papis","doi":"10.5603/jtm.97618","DOIUrl":"https://doi.org/10.5603/jtm.97618","url":null,"abstract":"Serum-based artificial tears are becoming increasingly popular worldwide. During the ISBT (International Society of Blood Transfusion) congress held in Gothenburg, Sweden, in 2023, research centers from various countries shared their experiences on the topic. Artificial tears are primarily used in the treatment of dry eye syndrome (DES), a condition associated with abnormal secretion of the tear film. Visual disturbances and headaches associated with DES have a negative impact on every day activity. In his 2021 study, Papas states that the prevalence of DES is growing and currently affects nearly 10% of the global population [1]. Because the procedure of collecting blood from older individuals or persons undergoing cancer treatment may often prove problematic, more attention","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136277868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zagadnienia dotyczące sztucznych łez poruszone na 33. Regionalnym Kongresie International Society of Blood Transfusion (ISBT) w Goteborgu, 17–21 czerwca 2023 roku 2023 年 6 月 17-21 日在哥德堡举行的国际输血学会（ISBT）第 33 届地区大会上提出的人工泪液问题
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.97403
Katarzyna Chmielewska, Joanna Janus, Jolanta Antoniewicz-Papis
{"title":"Zagadnienia dotyczące sztucznych łez poruszone na 33. Regionalnym Kongresie International Society of Blood Transfusion (ISBT) w Goteborgu, 17–21 czerwca 2023 roku","authors":"Katarzyna Chmielewska, Joanna Janus, Jolanta Antoniewicz-Papis","doi":"10.5603/jtm.97403","DOIUrl":"https://doi.org/10.5603/jtm.97403","url":null,"abstract":"","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135040889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected issues regarding cell therapies in light of reports presented at the 33rd Regional Congress of the International Society of Blood Transfusion (ISBT) in Gothenburg, June 17–21, 2023 根据2023年6月17日至21日在哥德堡举行的第33届国际输血学会(ISBT)地区大会上提交的报告，选择细胞疗法的问题
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.97617
Joanna Janus, Katarzyna Chmielewska, Jolanta Antoniewicz-Papis
{"title":"Selected issues regarding cell therapies in light of reports presented at the 33rd Regional Congress of the International Society of Blood Transfusion (ISBT) in Gothenburg, June 17–21, 2023","authors":"Joanna Janus, Katarzyna Chmielewska, Jolanta Antoniewicz-Papis","doi":"10.5603/jtm.97617","DOIUrl":"https://doi.org/10.5603/jtm.97617","url":null,"abstract":"The International Society of Blood Transfusion (ISBT) is a leading society combining a global community of professionals who share the knowledge on clinical and laboratory transfusion, as well as the safety of blood and blood components for the welfare of blood donors and patients. Every two years ISBT organizes international and regional congresses. On June 17–21, the 33rd Regional Congress was hosted by Göteborg (Sweden). This congress was organized jointly with the Swedish Society for Clinical Immunology and Transfusion Medicine (KITM, Svensk Förening för Klinisk Immunologi och Transfusionsmedicin). The congress agenda included: Nordic Day (June 17), during which reports from five Scandinavian countries were presented, Academy Day (June 18), during which educational lectures covering practical aspects of the most recent topics in transfusion medicine were presented, three days (June 19–21) of sessions presenting the latest reports in the field of transfusion medicine and the related fields. This paper presents some selected issues related to cell therapies presented during the Congress.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"2013 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136277869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New classification criteria for antiphospholipid syndrome — 2023 抗磷脂综合征新分类标准- 2023
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.97795
Jacek Musiał
{"title":"New classification criteria for antiphospholipid syndrome — 2023","authors":"Jacek Musiał","doi":"10.5603/jtm.97795","DOIUrl":"https://doi.org/10.5603/jtm.97795","url":null,"abstract":"Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the clinical presence of thrombotic episodes, and — in women — obstetric complications with the laboratory presence of antiphospholipid antibodies in blood. The main objective of this report is to present in detail the new American College of Rheumatology (ACR)/Alliance of Associations for Rheumatology (EULAR) APS classification criteria. According to EULAR methodology they include entry criterion indispensable to initiate classification process and contain 8 clinical and laboratory domains allowing to classify patient as having APS with 99% specificity.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135040878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nabyta hemofilia A leczona rekombinowanym czynnikiem VIIa z użyciem pompy infuzyjnej i wkłucia pośredniego 使用输液泵和间接注射重组因子 VIIa 治疗获得性血友病 A
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.94832
Wiktoria Ryżewska, Michał Witkowski, Tadeusz Robak
{"title":"Nabyta hemofilia A leczona rekombinowanym czynnikiem VIIa z użyciem pompy infuzyjnej i wkłucia pośredniego","authors":"Wiktoria Ryżewska, Michał Witkowski, Tadeusz Robak","doi":"10.5603/jtm.94832","DOIUrl":"https://doi.org/10.5603/jtm.94832","url":null,"abstract":"Nabyta hemofilia A to skaza krwotoczna o podłożu autoimmunologicznym, której leczenie obejmuje immunosupresję i leczenie omijające inhibitor, między innymi rekombinowanym czynnikiem VIIa (rFVIIa). Czas półtrwania rFVIIa jest krótki, co wymaga częstej podaży leku w celu utrzymania hemostazy. Zapewnienie ciągłego wlewu z pompy infuzyjnej zamiast podaży bolusów może się okazać nie tylko korzystne czasowo i finansowo, ale również bardziej bezpieczne dla pacjenta ze względu na możliwość utrzymania stałego poziomu czynnika omijającego inhibitor. Zazwyczaj rFVIIa jest podawany dożylnie poprzez cewnik wprowadzany obwodowo. Ciekawą alternatywę dla pacjentów poddawanym leczeniu dożylnemu lub dla osób z trudnym dostępem naczyniowym stanowi wkłucie pośrednie (midline insertion). Założenie takiego wkłucia jest bezpieczniejsze dla pacjenta, a ryzyko infekcji można porównać z ryzykiem przy zastosowaniu innych obwodowych cewników żylnych. Zastosowanie techniki wkłucia pośredniego stanowi mniejsze zagrożenie dla pacjentów i pozwala obniżyć koszty leczenia. W niniejszym artykule przedstawiono przypadek pacjentki z nabytą hemofilią A, której podawano rFVIIa przez cewnik pośredni (midline) przy użyciu pompy infuzyjnej.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"2014 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135040890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Testy agregometrii optycznej w diagnostyce trombocytopatii 诊断血小板增多症的光学聚集测试
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.95255
Daria Malarczyk, Edyta Odnoczko
{"title":"Testy agregometrii optycznej w diagnostyce trombocytopatii","authors":"Daria Malarczyk, Edyta Odnoczko","doi":"10.5603/jtm.95255","DOIUrl":"https://doi.org/10.5603/jtm.95255","url":null,"abstract":"Zaburzenia funkcji płytek krwi (PFD) to rzadko występująca, a zarazem heterogenna grupa chorób należących do skaz krwotocznych. Kompleksowa diagnostyka nieprawidłowej funkcji płytek krwi (PLT), tzw. trombocytopatii — wymaga zastosowania specjalistycznych badań. Złotym standardem diagnostyki PFD jest agregometria optyczna oparta na pomiarze światła widzialnego (LTA). Do próbki badanego osocza bagatopłytkowego dodawany jest w odpowiednim stężeniu określony agonista agregacji PLT (ADP, kwas arachidonowy, kolagen, rystocetyna, epinefryna). Na skutek interakcji z agonistą dochodzi do aktywacji i następczej agregacji płytek krwi. Powstawaniu agregatów płytkowych towarzyszy proporcjonalny wzrost przepuszczalności światła. W pracy przedstawiono zasadę metody LTA wraz z omówieniem podstawowego panelu agonistów agregacji płytek krwi. Ponadto scharakteryzowano mocne strony metody LTA i ograniczenia oraz porównano ją z pozostałymi alternatywnymi metodami diagnostyki PFD.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"95 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135040883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wybrane zagadnienia dotyczące terapii komórkowych w świetle doniesień prezentowanych na 33. Regionalnym Kongresie International Society of Blood Transfusion (ISBT) w Göteborgu, 17–21 czerwca 2023 roku 根据 2023 年 6 月 17-21 日在哥德堡举行的国际输血学会（ISBT）第 33 届地区大会上提交的报告选取的细胞疗法问题
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.97415
Joanna Janus, Katarzyna Chmielewska, Jolanta Antoniewicz-Papis
{"title":"Wybrane zagadnienia dotyczące terapii komórkowych w świetle doniesień prezentowanych na 33. Regionalnym Kongresie International Society of Blood Transfusion (ISBT) w Göteborgu, 17–21 czerwca 2023 roku","authors":"Joanna Janus, Katarzyna Chmielewska, Jolanta Antoniewicz-Papis","doi":"10.5603/jtm.97415","DOIUrl":"https://doi.org/10.5603/jtm.97415","url":null,"abstract":"","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135040888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acquired haemophilia A treated with recombinant factor VIIa by an infusion pump and midline catheter 重组VIIa因子在输注泵和中线导管下治疗获得性血友病A
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.2023.0007
Wiktoria Ryżewska, Michał Witkowski, Tadeusz Robak
{"title":"Acquired haemophilia A treated with recombinant factor VIIa by an infusion pump and midline catheter","authors":"Wiktoria Ryżewska, Michał Witkowski, Tadeusz Robak","doi":"10.5603/jtm.2023.0007","DOIUrl":"https://doi.org/10.5603/jtm.2023.0007","url":null,"abstract":"Acquired haemophilia A is an autoimmune bleeding disorder treated with immunosuppression and bypassing agents such as recombinant factor VIIa (rFVIIa). The half time of rFVIIa is short, which requires frequent bolus injections in order to maintain hemostasis. Providing a continuous pump infusion instead of bolus injections could not only be more time and cost- -efficient but also safer by maintaining a constant level of the bypassing agent. rFVIIa is administered intravenously usually through a peripheral venous catheter. In patients with prolonged intravenous treatment or difficult-to-access peripheral vasculature, midline long peripheral intravenous catheters are an interesting alternative. They have favourable dwell times and failure rates while maintaining the same risk of infection as other peripherally inserted central catheters. This technique has the potential to reduce the costs as well as risk to the patients. Herein, we report a case of a patient with AHA, who was treated with rFVIIa by an infusion pump and midline catheter.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136278817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nowe kryteria klasyfikacyjne zespołu antyfosfolipidowego — 2023 抗磷脂综合征的新分类标准 - 2023年
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.97598
Jacek Musiał
{"title":"Nowe kryteria klasyfikacyjne zespołu antyfosfolipidowego — 2023","authors":"Jacek Musiał","doi":"10.5603/jtm.97598","DOIUrl":"https://doi.org/10.5603/jtm.97598","url":null,"abstract":"Zespół antyfosfolipidowy (APS) jest ogólnoustrojowym schorzeniem autoimmunologicznym, który charakteryzuje się klinicznym występowaniem epizodów zakrzepowych, a u kobiet także powikłań położniczych, oraz laboratoryjną obecnością we krwi przeciwciał antyfosfolipidowych. Zasadniczym celem pracy jest szczegółowe przedstawienie nowych kryteriów klasyfikacyjnych APS, opracowanych przez American College of Rheumatology (ACR) i Alliance of Associations for Rheumatology (EULAR). Zgodnie z metodologią EULAR zawierają one kryterium wstępne, którego spełnienie jest niezbędne, aby rozpocząć proces klasyfikacji, oraz składają się z 8 domen klinicznych i laboratoryjnych, pozwalających zakwalifikować chorego jako cierpiącego na APS z 99-procentową swoistością.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135040702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Light transmission aggregometry in the diagnosis of thrombocytopathy 光透射聚集法在血小板病诊断中的应用
Global Journal of Transfusion Medicine Pub Date : 2023-09-30 DOI: 10.5603/jtm.2023.0006
Daria Malarczyk, Edyta Odnoczko
{"title":"Light transmission aggregometry in the diagnosis of thrombocytopathy","authors":"Daria Malarczyk, Edyta Odnoczko","doi":"10.5603/jtm.2023.0006","DOIUrl":"https://doi.org/10.5603/jtm.2023.0006","url":null,"abstract":"Platelet function disorders (PFD) are a rare and heterogeneous group of hemorrhagic diathesis. Comprehensive diagnostics of impaired platelet function (PLT) — the so called thrombocytopathy — requires the use of special testing. The gold standard for measurement/diagnostics of platelet function disorders is light transmission aggregometry (LTA). A platelet agonist (ADP, arachidonic acid, collagen, ristocetin, epinephrine) is added at an appropriate concentration to the sample of platelet-rich plasma. The interaction with the agonist leads to platelet activation and subsequent platelet aggregation. Aggregate formation is accompanied by a corresponding increase in light transmission. This review presents the principle of the LTA method, and a discussion of the basic panel of platelet aggregation agonists. In addition, the strengths and limitations of the LTA method are characterized and the method is compared with other alternative methods of PFD diagnostics.","PeriodicalId":52961,"journal":{"name":"Global Journal of Transfusion Medicine","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136278816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信